...
首页> 外文期刊>Journal of cancer education: the official journal of the American Association for Cancer Education >Development of a Plain Language Decision Support Tool for Cancer Clinical Trials: Blending Health Literacy, Academic Research, and Minority Patient Perspectives
【24h】

Development of a Plain Language Decision Support Tool for Cancer Clinical Trials: Blending Health Literacy, Academic Research, and Minority Patient Perspectives

机译:开发癌症临床试验的简单语言决策支持工具:混合健康素养,学术研究和少数群体患者观点

获取原文
获取原文并翻译 | 示例
           

摘要

Despite the promise of clinical trials for improving cancer care, less than 5% of all cancer patients participate. Racial/ethnic minorities continue to be underrepresented in cancer clinical trials (CCTs). To address this gap, we developed a plain language, web-based decision support tool (CHOICES DST) in English and Spanish to support decision-making about CCTs among Blacks and Hispanics. In phase 1 (information collection), we conducted qualitative interviews with 45 cancer patients, completed a thorough literature review, and reviewed results from a telephone survey of 1100 cancer patients. In phase 2 (content generation), we created the first iteration of the CHOICES DST. In phase 3 (usability testing), we gathered user experience and acceptability data from a small sample of cancer survivors (n = 9). The Knowledge, Empowerment, and Values Clarification (KEV) model of decision-making was developed based on data from phase 1. The KEV model and other phase 1 data allowed us to create the CHOICES DST platform. Usability testing of the CHOICES DST showed highly favorable responses from users, satisfaction with content, ease of navigation, and a desire to use the tool. Qualitative results identified addressable points that would benefit from content and navigation-related alterations. The final version of the CHOICES DST was well received and understood by Black and Hispanic participants, and adheres to the mandates for plain language communication. This research provides preliminary data that CHOICES DST holds promise for improving knowledge of CCTs and potentially improving informed decision-making about participation in trials.
机译:尽管有望改善癌症护理的临床试验,但不到5%的癌症患者参与。种族/少数群体在癌症临床试验(CCTS)方面持续不足。为了解决这一差距,我们开发了一种简单的语言,以英语和西班牙语为基础的基于Web的决策支持工具(选择DST),以支持关于黑人和西班牙裔人中CCT的决策。在第1阶段(信息收集)中,我们与45名癌症患者进行了定性访谈,完成了彻底的文献综述,并从1100名癌症患者的电话调查中审查了结果。在第2阶段(内容生成)中,我们创建了选择DST的第一次迭代。在第3阶段(可用性测试)中,我们收集了来自癌症幸存者样本的用户体验和可接受性数据(n = 9)。基于来自第1阶段的数据开发了决策的知识,赋权和价值澄清(KEV)模型和其他阶段1数据允许我们创建DST平台。选择DST的可用性测试显示了来自用户的高度有利的响应,对内容,易于导航的满意度以及使用该工具的愿望。定性结果确定了将从内容和导航相关的更改中受益的可寻址点。选择DST的最终版本受到黑白和西班牙裔参与者的好评,并理解,并遵守纯语言沟通的任务。本研究提供了选择DST的初步数据,以提高对CCTS的知识,并可能改善关于参与审判的知情决策。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号